Keywords: re: Reported Opinion, Trial; Patent Infringement; 35 U.S.C. § 202(c)(4); Bayh-Dole Act; Paid-Up License; Affirmative Defense. (TQ)
Keywords: Material Misrepresentation, Labor Unrest, Past Performance Evaluation, Responsibility Determination, Technical Evaluation, Motion to Dismiss, MJAR
Keywords: re: Reported Opinion; Motion to Dismiss; RCFC 12(b)(1); Standing; Motion for Summary Judgment; RCFC 56; The Miller Act; Third-Party Beneficiary; Retainage.
Keywords: re: Order on Motion for Summary Judgment, Reported Opinion Overtime compensation; 38 U.S.C. § 7453(e); credit hours; flexible schedule employees; 5 U.S.C. § 6121-26
Keywords: re: Reported Opinion -- Postaward Bid Protest; Operation of a Job Corps Center; Cross-Motions for Judgment on the Administrative Record; Evaluation of Proposals; Relevance of Past Performance; Subcontractor Past Performance; Unequal Treatment; Price Realism; Professional Employee Compensation, FAR 52.222-46; Best Value Determination; Permanent Injunction
Keywords: re: Reported Opinion: Subject Matter Jurisdiction; RCFC 12(h)(3); RCFC 41(a)(2); Patent License Agreement; 28 U.S.C. § 1498(a).
Keywords: re: Law Enforcement Availability Pay Act of 1994; 5 U.S.C. § 5545a; Premium Pay; Availability Pay; Overtime Pay; Failure to State a Claim; RCFC 12(b)(6).
Keywords: re: Reported Opinion; Motion to Dismiss - Rule 12(b)(1); Motion for Oral Argument; Pro Se Complaint; Dismissal for Lack of Jurisdiction; RCFC 12(h)(3). (TQ)
Keywords: re: Reported Opinion; Post Award Bid Protest; Small Business Administration; Service-Disabled Veteran Owned Small Business; 13 C.F.R. § 125.11; Unconditional Ownership. (TQ)
Keywords re [38]: Alleged breach of contract; cost accounting standard 420; research and development costs; effect of a Forward Pricing Rate Agreement.
Keywords: re: Reported Opinion: Summary Judgment; Hatch-Waxman Act; Tax Deduction; Capitalization; Woodward; Patent Litigation Costs; Origin of the Claim; 35 U.S.C. § 271(e)(2); I.R.C. § 162(a); I.R.C. § 263(a); 26 C.F.R. § 1.263(a)-4; Abbreviated New Drug Application (ANDA); Generic Drugs; FDA.